Cargando…
Ruboxistaurin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Clinical Trials
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. Protein kinase C (PKC) inhibitor's has been thought to be a potential disease modifying drug's in DPN as it slows or reverse neuropathy's progression. To assesses the efficacy and safety of...
Autores principales: | Bansal, Dipika, Badhan, Yogesh, Gudala, Kapil, Schifano, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816139/ https://www.ncbi.nlm.nih.gov/pubmed/24199167 http://dx.doi.org/10.4093/dmj.2013.37.5.375 |
Ejemplares similares
-
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
por: Gudala, Kapil, et al.
Publicado: (2013) -
Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008–2012)
por: Bansal, Dipika, et al.
Publicado: (2015) -
Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting
por: Bansal, Dipika, et al.
Publicado: (2014) -
Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-Analysis
por: Gudala, Kapil, et al.
Publicado: (2015) -
Usefulness of four commonly used neuropathic pain screening questionnaires in patients with chronic low back pain: a cross-sectional study
por: Gudala, Kapil, et al.
Publicado: (2017)